MICROPORT CARDIOFLOW MEDTECH CORPORATION Financials MicroPort CardioFlow Medtech Corporation
Equities
2160
KYG6082P1054
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.14 HKD | +1.79% |
|
+1.79% | -29.63% |
| 10/05 | MicroPort CardioFlow Medtech's Medical Device Secures Breakthrough Designation from FDA | MT |
| 16/04 | Microport Cardioflow Inks Services Deal with Subsidiary | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 7,579 | 5,554 | 3,552 | 2,543 | - | - |
| Enterprise Value (EV) 1 | 5,493 | 3,783 | 3,552 | 2,543 | 2,543 | 2,543 |
| P/E ratio | -39.4 x | -12.1 x | -7.36 x | -14.8 x | -226 x | 25.3 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 37.7 x | 22.1 x | 10.6 x | 5.67 x | 4.24 x | 3.3 x |
| EV / Revenue | 37.7 x | 22.1 x | 10.6 x | 5.67 x | 4.24 x | 3.3 x |
| EV / EBITDA | -66 x | -38.5 x | -12.8 x | -13.4 x | -59.1 x | 29.2 x |
| EV / FCF | -28.1 x | -24.3 x | - | -11.8 x | -39.7 x | 196 x |
| FCF Yield | -3.56% | -4.11% | - | -8.45% | -2.52% | 0.51% |
| Price to Book | 2.37 x | 2.02 x | - | 1.17 x | 1.17 x | 1.17 x |
| Nbr of stocks (in thousands) | 24,03,564 | 24,09,385 | 24,12,478 | 24,12,593 | - | - |
| Reference price 2 | 3.153 | 2.305 | 1.472 | 1.054 | 1.054 | 1.054 |
| Announcement Date | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 21.5 | 103.9 | 200.8 | 251 | 336.2 | 448.5 | 599.3 | 770.2 |
| EBITDA 1 | - | -228 | -114.8 | -144.4 | -277.2 | -190 | -43 | 87 |
| EBIT 1 | - | -252.5 | -159.2 | -222.6 | -313.7 | -204.8 | -29.07 | 77.54 |
| Operating Margin | - | -242.94% | -79.3% | -88.67% | -93.29% | -45.67% | -4.85% | 10.07% |
| Earnings before Tax (EBT) 1 | - | -398.1 | -182.7 | -451.3 | -463.6 | -169.4 | -8.455 | 106.5 |
| Net income 1 | -144.5 | -398.1 | -183.3 | -454.4 | -471.5 | -169.4 | -8.788 | 99.47 |
| Net margin | -672.13% | -383.02% | -91.26% | -181.02% | -140.25% | -37.77% | -1.47% | 12.92% |
| EPS 2 | - | -0.2300 | -0.0800 | -0.1900 | -0.2000 | -0.0712 | -0.004670 | 0.0417 |
| Free Cash Flow 1 | - | -141.4 | -269.9 | -228.5 | - | -215 | -64 | 13 |
| FCF margin | - | -136.01% | -134.43% | -91.02% | - | -47.93% | -10.68% | 1.69% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 14.94% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 13.07% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 25/01/21 | 30/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | 597 | 2,086 | 1,771 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -141 | -270 | -228 | - | -215 | -64 | 13 |
| ROE (net income / shareholders' equity) | - | - | -13.3% | -15.5% | - | -7.25% | -0% | 4.04% |
| ROA (Net income/ Total Assets) | - | -48% | -8.19% | -14.3% | - | -7% | - | 0.9% |
| Assets 1 | - | 829 | 2,237 | 3,182 | - | 2,420 | - | 11,052 |
| Book Value Per Share 2 | - | -5.700 | 1.330 | 1.140 | - | 0.9000 | 0.9000 | 0.9000 |
| Cash Flow per Share | - | -0.0600 | -0.0700 | -0.0800 | - | - | - | - |
| Capex 1 | - | 62.6 | 108 | 45.9 | - | 65 | 50.5 | 90 |
| Capex / Sales | - | 60.23% | 54% | 18.3% | - | 14.49% | 8.43% | 11.69% |
| Announcement Date | 25/01/21 | 30/03/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.054
CNY
Average target price
2.412
CNY
Spread / Average Target
+128.84%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.63% | 352M | |
| +10.39% | 126B | |
| -6.86% | 10.96B | |
| +2.52% | 8.97B | |
| +38.96% | 5.56B | |
| -17.50% | 4.99B | |
| +8.36% | 3.44B | |
| -8.84% | 2.8B | |
| -7.52% | 2.18B | |
| -3.00% | 2.16B |
- Stock Market
- Equities
- 2160 Stock
- Financials MicroPort CardioFlow Medtech Corporation